![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
PREVIEW
Intravenous tissue plasminogen activator (tPA) is an important intervention in the treatment of acute ischemic stroke. However, if not administered according to strict guidelines, this therapy carries a substantial risk of intracerebral hemorrhage. The authors review trial data and patient selection criteria for tPA therapy and offer recommendations on effective stroke management in a clinical setting.